Evidence map›Paper›PMID 35181680›Full record

ArticleScientific reports2022

Performances of rapid and connected salivary RT-LAMP diagnostic test for SARS-CoV-2 infection in ambulatory screening.

Francisco Santos Schneider, Laurence Molina, Marie-Christine Picot, Nicolas L'Helgoualch, Julien Espeut, Pierre Champigneux, Mellis Alali, Julie Baptiste, Lise Cardeur, Christophe Carniel and 22 more

Registry-linked trialOpen access · goldAbstract readControlled Clinical Trial
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04337424 (Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2), which is not on this map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04337424 completednot on this map

Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2

TypeobservationalSponsorUniversity Hospital, MontpellierRan2020 to 2020Enrolled627ConditionsSARS-CoV-2ArmsSampling salivary
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. SARS-CoV-2 antigen tests for screening of healthcare workers; experience with over 48,000 combined antigen tests and RT-PCR tests.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2023
    Article
  9. Article
  10. Evaluation of theJournal of clinical virology plus · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 6 institutions in 2 countries.

Francisco Santos Schneider *Sys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Laurence Molina *Sys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Marie-Christine Picot *Clinical Research and Epidemiology Unit, Department of Medical Information, Montpellier University Hospital, University of Montpellier, Montpellier, France.
Nicolas L'HelgoualchSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Julien EspeutSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Pierre ChampigneuxSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Mellis AlaliSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Julie BaptisteSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Lise CardeurSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Christophe CarnielVogo, Montpellier, France.
Martin DavySys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Daniel DedisseVogo, Montpellier, France.
Benjamin DubucSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Hugo FenechSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Vincent FoulongnePCCEI, Univ Montpellier, INSERM, EFS, Univ Antilles, Montpellier, France.
Carole Fruchart GaillardCEA, INRAE, Department of Medicines and Healthcare Technologies (DMTS), University of Paris-Saclay, SIMoS, Gif-sur-Yvette, France.
Florence GaltierINSERM Centre Investigation Clinique 1411, University Hospital, Montpellier, France.
Alain MakinsonInfectious Diseases Department, Montpellier University Hospital, Montpellier, France.
Grégory MarinClinical Research and Epidemiology Unit, Department of Medical Information, Montpellier University Hospital, University of Montpellier, Montpellier, France.
Raissa Medina SantosSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
David MorquinInfectious Diseases Department, Montpellier University Hospital, Montpellier, France.
Alimata OuedraogoSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Alexandra Prieux LejeuneSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Marine QuenotSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Pierre KeiflinVogo, Montpellier, France.
Francisco Checa RoblesSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Carolina Rodrigues RegoSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Nicolas SalvetatSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Charline TrentoSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Diana VetterSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France.
Franck MolinaSys2Diag UMR9005 CNRS ALCEN, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 40182, 34184, Montpellier, CEDEX 4, France. franck.molina@sys2diag.cnrs.fr.
Jacques ReynesInfectious Diseases Department, Montpellier University Hospital, Montpellier, France.
Centre National de la Recherche Scientifique · FRModélisation et Ingénierie des Systèmes Complexes Biologiques pour le Diagnostic · FRUniversité de Montpellier · FRInserm · FRCentre Hospitalier Universitaire de Montpellier · FRInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the context of social events reopening and economic relaunch, sanitary surveillance of SARS-CoV-2 infection is still required. Here, we evaluated the diagnostic performances of a rapid, extraction-free and connected reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay on saliva. Nasopharyngeal (NP) swabs and saliva from 443 outpatients were collected simultaneously and tested by reverse-transcription quantitative PCR (RT-qPCR) as reference standard test. Seventy-one individuals (16.0%) were positive by NP and/or salivary RT-qPCR. Sensitivity and specificity of salivary RT-LAMP were 85.9% (95%CI 77.8-94.0%) and 99.5% (98.7-100%), respectively. Performances were similar for symptomatic and asymptomatic participants. Moreover, SARS-CoV-2 genetic variants were analyzed and no dominant mutation in RT-LAMP primer region was observed during the period of the study. We demonstrated that this RT-LAMP test on self-collected saliva is reliable for SARS-CoV-2 detection. This simple connected test with optional automatic results transfer to health authorities is unique and opens the way to secure professional and social events in actual context of economics restart.

Indexed as

AdultAsymptomatic InfectionsCOVID-19 Nucleic Acid TestingFemaleHumansMaleMass ScreeningMiddle AgedMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesSalivaSARS-CoV-2Viral LoadYoung Adult

Identifiers

PMID35181680
PMCPMC8857239
OpenAlexW4213211239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.